United States Biotechnology & Medical Research

CDT Equity Inc (CDT)

Track

CDT Equity Inc experienced four insider trading transactions over the past ninety days, all involving sales by Mark Andrew Taylor. These disposals totaled approximately 2.95 million dollars. This activity follows a period where the stock price appreciated by 84.9 percent, preceding the most recent June earnings report.
Ticker: CDT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for CDT Equity Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Taylor Mark Andrew Large shareholder
Transaction date
Sale
Price
69.27
Quantity 36,639 -26.2%
Value US$3,801,315
Taylor Mark Andrew Large shareholder
Transaction date
Sale
Price
87.94
Quantity 60,774 -36.4%
Value US$2,960,853
Taylor Mark Andrew Large shareholder
Transaction date
Sale
Price
194.74
Quantity 63,857 -41.6%
Value US$3,518,471
Taylor Mark Andrew Large shareholder
Transaction date
Sale
Price
0.71
Quantity 5,000 -0.3%
Value US$3,526
3.5
Nirland Ltd Large shareholder
Transaction date
Sale
Price
0.10
Quantity 939,009 -13.4%
Value US$96,530
3.5
Nirland Ltd Large shareholder
Transaction date
Sale
Price
0.10
Quantity 1,368,991 -16.3%
Value US$140,458
3.5
Nirland Ltd Large shareholder
Transaction date
Sale
Price
0.10
Quantity 1,500,000 -15.2%
Value US$156,450
3.5
Nirland Ltd Large shareholder
Transaction date
Sale
Price
0.10
Quantity 333,177 -3.3%
Value US$34,251
3.5
Nirland Ltd Large shareholder
Transaction date
Sale
Price
0.11
Quantity 1,250,000 -10.9%
Value US$141,375
3.5
Nirland Ltd Large shareholder
Transaction date
Sale
Price
0.12
Quantity 1,016,823 -8.1%
Value US$122,019
3.7
Regan Andrew Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.26
Quantity 1,514,100 -89.5%
Value US$391,092
3.7
Regan Andrew Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.32
Quantity 10,244,392 -85.8%
Value US$3,246,448
3.7
Regan Andrew Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.25
Quantity 1,005,200 -7.8%
Value US$248,385
3.7
Regan Andrew Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.25
Quantity 1,389,820 -9.7%
Value US$343,425
3.7
Regan Andrew Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.29
Quantity 300,000 -2.1%
Value US$87,000
3.7
Regan Andrew Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.30
Quantity 582,952 -3.8%
Value US$173,253
3.7
Regan Andrew Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.33
Quantity 150,000 -1.0%
Value US$50,070
3.7
Regan Andrew Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.44
Quantity 77,681 -0.5%
Value US$33,853
3.7
Regan Andrew Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.51
Quantity 35,923 -0.2%
Value US$18,321
3.7
Regan Andrew Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.64
Quantity 1,000 -0.0%
Value US$640
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-23 2026-06-18 S Sale
Taylor Mark Andrew
Large shareholder
36,639 -26.2%
69.27
US$3,801,315 		36,639 -26.2% 69.27 US$3,801,315
2026-06-23 2026-06-18 S Sale
Taylor Mark Andrew
Large shareholder
60,774 -36.4%
87.94
US$2,960,853 		60,774 -36.4% 87.94 US$2,960,853
2026-06-23 2026-06-18 S Sale
Taylor Mark Andrew
Large shareholder
63,857 -41.6%
194.74
US$3,518,471 		63,857 -41.6% 194.74 US$3,518,471
2026-06-23 2026-06-18 S Sale
Taylor Mark Andrew
Large shareholder
5,000 -0.3%
0.71
US$3,526 		5,000 -0.3% 0.71 US$3,526
2024-10-07 2024-10-07 S Sale
3.5
Nirland Ltd
Large shareholder
939,009 -13.4%
0.10
US$96,530 		939,009 -13.4% 0.10 US$96,530
2024-10-07 2024-10-04 S Sale
3.5
Nirland Ltd
Large shareholder
1,368,991 -16.3%
0.10
US$140,458 		1,368,991 -16.3% 0.10 US$140,458
2024-10-07 2024-10-03 S Sale
3.5
Nirland Ltd
Large shareholder
1,500,000 -15.2%
0.10
US$156,450 		1,500,000 -15.2% 0.10 US$156,450
2024-10-02 2024-10-02 S Sale
3.5
Nirland Ltd
Large shareholder
333,177 -3.3%
0.10
US$34,251 		333,177 -3.3% 0.10 US$34,251
2024-10-02 2024-10-01 S Sale
3.5
Nirland Ltd
Large shareholder
1,250,000 -10.9%
0.11
US$141,375 		1,250,000 -10.9% 0.11 US$141,375
2024-10-02 2024-09-30 S Sale
3.5
Nirland Ltd
Large shareholder
1,016,823 -8.1%
0.12
US$122,019 		1,016,823 -8.1% 0.12 US$122,019
2024-09-19 2024-07-17 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
1,514,100 -89.5%
0.26
US$391,092 		1,514,100 -89.5% 0.26 US$391,092
2024-09-19 2024-07-16 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
10,244,392 -85.8%
0.32
US$3,246,448 		10,244,392 -85.8% 0.32 US$3,246,448
2024-09-19 2024-07-15 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
1,005,200 -7.8%
0.25
US$248,385 		1,005,200 -7.8% 0.25 US$248,385
2024-09-19 2024-07-12 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
1,389,820 -9.7%
0.25
US$343,425 		1,389,820 -9.7% 0.25 US$343,425
2024-09-19 2024-07-11 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
300,000 -2.1%
0.29
US$87,000 		300,000 -2.1% 0.29 US$87,000
2024-09-19 2024-07-11 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
582,952 -3.8%
0.30
US$173,253 		582,952 -3.8% 0.30 US$173,253
2024-09-19 2024-07-10 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
150,000 -1.0%
0.33
US$50,070 		150,000 -1.0% 0.33 US$50,070
2024-09-19 2024-07-09 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
77,681 -0.5%
0.44
US$33,853 		77,681 -0.5% 0.44 US$33,853
2024-09-19 2024-07-08 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
35,923 -0.2%
0.51
US$18,321 		35,923 -0.2% 0.51 US$18,321
2024-09-19 2024-07-03 S Sale
3.7
Regan Andrew
Non-Executive Director Large shareholder
1,000 -0.0%
0.64
US$640 		1,000 -0.0% 0.64 US$640
Explore more

More insider trading research around CDT Equity Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America